Ono Pharmaceutical (OTCMKTS:OPHLF) Shares Gap Down – Here’s What Happened

Shares of Ono Pharmaceutical Co. (OTCMKTS:OPHLF) gapped down prior to trading on Wednesday . The stock had previously closed at $16.00, but opened at $14.00. Ono Pharmaceutical shares last traded at $14.00, with a volume of 100 shares changing hands.

Ono Pharmaceutical Trading Down 12.5%

The company has a market cap of $6.58 billion, a PE ratio of 15.73 and a beta of 0.23. The company has a current ratio of 3.02, a quick ratio of 2.56 and a debt-to-equity ratio of 0.10. The firm has a fifty day moving average of $15.32 and a two-hundred day moving average of $13.15.

Ono Pharmaceutical (OTCMKTS:OPHLF) last announced its quarterly earnings results on Monday, February 2nd. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.11. Ono Pharmaceutical had a net margin of 12.29% and a return on equity of 7.76%. The business had revenue of $892.70 million during the quarter, compared to analysts’ expectations of $727.58 million.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co, Ltd., founded in 1717 and headquartered in Osaka, Japan, is a research‐based pharmaceutical company specializing in the discovery, development and marketing of innovative therapies. With origins as a traditional pharmacy, Ono has grown into a global biopharmaceutical entity focused on delivering new treatment options across several therapeutic areas, including oncology, immunology, cardiovascular and antiviral diseases. The company conducts comprehensive research programs spanning early drug discovery through to clinical development.

One of Ono’s most recognized products is the immune checkpoint inhibitor nivolumab, marketed in collaboration with Bristol-Myers Squibb under the trade name Opdivo.